Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01618539 · ClinicalTrials.gov registry record
Correlation of Bispectral Index Score and Total Intravenous Anesthesia (TIVA)
A clinical trial, sponsored by Rutgers, The State University of New Jersey.
- Terminated
- Registry status
- 31
- Enrollment target
NCT01618539 is a clinical trial that was terminated before completion, run by Rutgers, The State University of New Jersey. The registered enrollment target is 31 participants.
The verdict
NCT01618539 was terminated before completion, sponsored by Rutgers, The State University of New Jersey.
- TERMINATED
- Registry status
- 31 participants
- Enrollment target
Study Summary
General Anesthesia is usually produced by an intravenous agent and then maintained with a breathing agent till the surgery is completed. However, there is a recent trend to produce and maintain general anesthesia solely with an intravenous agent, such as propofol, in view of its advantages. This delivery method is called Total Intravenous Anesthesia (TIVA). The depth of general anesthesia can be measured by an anesthetic depth monitoring device called Bispectral Index (BIS). The use of BIS to determine the depth of anesthesia has been well established whenever a breathing agent is used to maintain general anesthesia. However, the validity of using BIS with TIVA has not been adequately investigated. This study will compare the BIS values at different doses of TIVA in order to establish any correlation between the two. If such a correlation is established, BIS monitoring can safely be recommended to determine anesthetic depth under TIVA.
Interventions
- DRUG propofol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01618539
The ClinicalTrials.gov registry entry for NCT01618539 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which propofol is the first listed.
NCT01618539 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01618539 about?
NCT01618539 is a clinical study titled "Correlation of Bispectral Index Score and Total Intravenous Anesthesia (TIVA)". General Anesthesia is usually produced by an intravenous agent and then maintained with a breathing agent till the surgery is completed. However, there is a recent trend to produce and maintain general anesthesia solely with an intravenous agent, such as propofol, in view of its advantages. This del...
What is the current status of trial NCT01618539?
This trial is currently terminated. The enrollment target is 31 participants. The study started on 2012-06. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01618539?
The interventions under investigation include: propofol (DRUG).
Who is sponsoring clinical trial NCT01618539?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.